Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo

N/AUnknownNCT03377998

Cairo University100 enrolled

Overview

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

100

Conditions

Erythroid Differentiation Regulator 1 (Erdr1) Cytokine

Interventions

skin biopsyOTHER

Skin biopsy for measuring tissue levels of the Erythroid differentiation regulator 1 (Erdr1) cytokine will be taken from the lesional skin of patients of vitiligo and from normal skin of healthy controls.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with generalized non-segmental vitiligo. * Both sexes. * Age \>18 years old. * New cases or cases not receiving any medication for at least 3 months ago. Exclusion Criteria: * Segmental or Universal vitiligo * Autoimmune diseases

Outcomes

Primary Outcomes

Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo

Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo and comparing its level in normal subjects

Time frame: 6 months

Central Contacts

Maha Fathy Elmasry, MD

CONTACT

00201222633740 mahafathy1214@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.